SlideShare a Scribd company logo
Presented By:
Maria Kousar (Trainee Teacher)
Senior Electives (Clinical Education)
POST RN BSN session 2021 - 2022
2nd year Semester IV
Parkinson’s disease (PD) 0
By the end of this presentation learners will be able:
 To Define Parkinson’s disease
 To develop knowledge about stages of Parkinson's disease
 To explain causes and clinical manifestation of Parkinson's disease
 To enlist risk factors and etiology of Parkinson's disease
 To describe diagnostic evaluation of Parkinson's disease
 To elaborate Medical management of PD
 To explain nursing management of PD
Parkinson’s disease (PD) 1
Parkinson's disease is a degenerative and
slowly progressive disease that affects the
nervous system and the parts of the body
which controlled by nerves.
Parkinson's disease is caused by a loss of
nerve cells in the part of the brain called
the substantia nigra. Nerve cells in this
part of the brain are responsible for
producing a chemical called dopamine
Parkinson’s disease (PD) 2
 Genetics
 Environmental factors
 Drug induced (anti psychotic drugs)
 Cerebrovascular disease (Its attack damage the brain cells)
 The presence of Lewy bodies (Clumps of specific substances within brain cells)
 Head trauma
 Advancing of age
 Gender
Parkinson’s disease (PD) 3
Destruction of dopmenergic neuronal cells in the
substantia nigra in the basal ganglia
Neuronal cells loss and depigmentation
Degeneration of dopmenergic activity
Depletion of dopamine store
Imbalance between acetylcholine and
dopamine neurotransmitter
Etiological Factors
Environmental factors
Genetics
Brain Trauma
Sign and symptoms
Tremors
Rigidity
Akinesia
Postural instability
Impairment of extrapyramidal tract
controlling body movements
Parkinson’s disease (PD) 4
Parkinson’s disease (PD) 5
Tremors (pill rolling
usually during rest)
Rigidity (stiffness
of muscles)
Bradykinesia (slow and small
movements)
Postural changes
(imbalance, falls)
Parkinson’s disease (PD) 6
 Resting tremor
 Mask like facial expressions
 Stiff or achy limbs
 Rigidity
 Stooped posture (shuffle walk)
 Impaired posture and balance
 Loss of automatic movements
 Speech changes (low or soft voice)
 Trouble getting out from chair
Parkinson’s disease (PD) 7
 Patient history
 Detailed physical examination
 Complete neurological examination
 PET scan (positron emission topography)
 MRI (Magnetic resonance imaging)
Parkinson’s disease (PD) 8
 Dopamine agonists
 MAO B inhibitors
 Antiparkinson: drugs such as Levodopa (L-dopa); carbidopa-levodopa (Sinemet) is used to
control tremors and rigidity; converted to dopamine in the basal ganglia.
 Antiviral drugs: such as Amantadine hydrochloride (Symmetrel) is used to control tremor and
rigidity by increasing the release of dopamine to the basal ganglia.
 Anticholinergics: such as Trihexyphenidyl (Artane); benztropine mesylate (Cogentin) is used to
block acetylcholine stimulated nerves that lead to tremors.
 Other Drugs: Antihistamines are sometimes prescribed with the anticholinergics to inhibit
dopamine uptake; bromocriptine mesylate, a dopamine antagonist, is ordered to stimulate
dopaminergic receptors.
Parkinson’s disease (PD) 9
 Deep Brain Stimulation:
In deep brain stimulation (DBS),
surgeons implant electrodes into a
specific part of the brain. The electrodes
are connected to a generator implanted in
your chest near your collarbone that
sends electrical pulses to your brain and
may reduce your Parkinson's disease
symptoms.
Parkinson’s disease (PD) 10
 Assess neurological status.
 Assess ability to swallow and chew.
 Provide high-calorie, high-protien, high-fiber soft diet with small,
frequent feedings.
 Increase fluid intake to 2000 ml/day.
 Monitor for constipation.
 Promote independence along with safety measures.
 Avoid rushing the client with activities.
 Assist with ambulation and provide assistive devices.
Parkinson’s disease (PD) 11
 Instruct the client to wear low-heeled shoes.
 Encourage the client to lift feet when walking and avoid prolonged
sitting.
 Provide a firm mattress, and position the client prone, without a pillow, to
facilitate proper posture.
 Instruct in proper posture by teaching the client to hold the hands behind
the back to keep the spine and neck erect.
 Promote physical therapy and rehabilitation.
 Administer anticholinergic medications as prescribed to treat tremors and
rigidity and to inhibit the action of acetylcholine.
Parkinson’s disease (PD) 12
 Imbalanced nutrition less than body requirements related to
parkinsonism changes in musculature and facial rigidity as
evidenced by weight lose.
 Impaired Physical Mobility related to Parkinson’s disease as
evidenced by immobility and weakness.
 Impaired Verbal Communication related to rigidity of facial
muscles evidenced by inability to speak
 Constipation related to diminished motor function and
inactivity.
Parkinson’s disease (PD) 13
 Assess patient’s ability to eat to provide information regarding factors
associated with reduced intake of nutrients.
 Weight patient daily, on the same scale and same time if possible Provides
information about weight loss or gain.
 Instruct patient with techniques that initiate movement change from side to
side helps to start the leg movement.
 Provide warm baths and massages helps relax muscles and relieve painful
muscle spasms that accompany rigidity.
 Assess the patient’s ability to speak, language deficit, cognitive or sensory
impairment his helps identify problem areas and speech patterns to help
establish a plan of care.
Parkinson’s disease (PD) 14
 Use simple, direct questions requiring one-word answers promotes self-
confidence of the patient who is able to achieve some degree of speech or
communication.
 Instruct patient to perform daily exercise that will increase muscle strength
and exercise prevent contractures.
 Refer patient to a physical therapist to be helpful in developing an
individualized exercise program and can provide instruction to the patient and
caregiver on exercising safely.
 When communicating with patient, face patient and maintain eye contact
Clarity, brevity, and time provided for responses promotes the opportunity for
successful speech
Parkinson’s disease (PD) 15
 To assist in maintaining balance, concentrate on taking larger steps with feet
apart, keeping back straight and swinging the arms.
 To overcome Akinesia, tape the “frozen” leg to initiate movement.
 To reduce tremors, hold objects (coins, keys, or purse) in the hand.
 To obtain partial control of tremors when seated, grasp chair arms.
 To reduce rigidity before exercise, take a warm bath.
 Teach the patient to eliminate loose carpeting, install grab bars, and elevate the
toilet seat.
Parkinson’s disease (PD) 16
 Assist with ambulation and provide
assistive devices.
 Assist during meals
 Maintain fluid balance
 Emotional support
 Provide physiotherapy services to
the patient .
Encephalitis
In olders above
60y of age
 Tremors
 Rigidity
 Bradykinesia
 Postural changes
 MAO B
 Dopamine Agonist
 Antiparkinson’s
 Anticholinergics
 I/v fluid therapy
Definition
Pharmacological
Treatment
4 cardinal
S & S
Diagnostic criteria
N-Management
PD is a slowly
progressive and
degenerative disease of
the brain
 Health history
 Complete physical
examination
 Complete neurological
examination
 CT- scan
 MRI
Most
commonly in
males
Parkinson’s disease (PD) 17
Parkinson’s disease (PD) 18
1)The slowly progressive and degenerative disease of the
brain is called..
a) Meningitis
b) Encephalitis
c) Parkinson's disease
d) Brain abscess
2) There are how many cardinal symptoms ..
a) 3
b) 4
c) 6
d) 5
Parkinson’s disease (PD) 19
3) Parkinson's is disease most common in..
a) Males
b) Females
c) Both
d) None of above
4) Which of the following is recognized as an initial cardinal
sign present early in Parkinson disease?
a) Bradykinesia
b) Balance impairment
c) Hyperkinesia
d) Dysarthriass
Parkinson’s disease (PD) 20
• Jankovic, J. (2008). Parkinson’s disease: clinical features and
diagnosis. Journal of neurology, neurosurgery &
psychiatry, 79(4), 368-376.
• Dauer, W., & Przedborski, S. (2003). Parkinson's disease:
mechanisms and models. Neuron, 39(6), 889-909.
• Lotharius, J., & Brundin, P. (2002). Pathogenesis of
Parkinson's disease: dopamine, vesicles and α-
synuclein. Nature Reviews Neuroscience, 3(12), 932-942.
• https://youtu.be/AZRq15AD4yA
Parkinson’s disease (PD) 21
Parkinson’s disease (PD) 22
Parkinson’s disease (PD) 23

More Related Content

Similar to parkinsons disease.pptx

Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
Kenneth Kekal
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
Mr. MOHD FAHAD
 
Parkinson’s disease and exercise
Parkinson’s disease and exerciseParkinson’s disease and exercise
Parkinson’s disease and exerciseammiller3
 
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
Srinitha Busam
 
Cerebral palsy ppt
Cerebral palsy pptCerebral palsy ppt
Cerebral palsy ppt
Dr.Thirunagalinga Pandiyan
 
Parkinson handbook
Parkinson handbookParkinson handbook
Parkinson handbookOpti Mizam
 
Parkinson disease pd
Parkinson disease pdParkinson disease pd
Parkinson disease pd
Anila George
 
Dr Jim George - Parkinson's Disease Service in Cumbria
Dr Jim George - Parkinson's Disease Service in CumbriaDr Jim George - Parkinson's Disease Service in Cumbria
Dr Jim George - Parkinson's Disease Service in Cumbria
Cumbria Partnership
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Diseaseguest27ee33
 
Degenerativers
DegenerativersDegenerativers
Degenerativersmycomic
 
Parkinson’s disease and exercise
Parkinson’s disease and exerciseParkinson’s disease and exercise
Parkinson’s disease and exerciseammiller3
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
Anindya Banerjee
 
Cerebral Palsy
Cerebral PalsyCerebral Palsy
Cerebral Palsy
Endang lisnani
 
my seminar p.p
my seminar p.pmy seminar p.p
my seminar p.pAsal Sadeq
 
Parkinson study case
Parkinson study caseParkinson study case
Parkinson study case
Boge Trcoski
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
HIRENGEHLOTH
 
2009 Summer Newsltr Parkinson Ali
2009  Summer Newsltr Parkinson Ali2009  Summer Newsltr Parkinson Ali
2009 Summer Newsltr Parkinson AliJeffery Massey
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
MichaelJoseph167
 
Sharp Home Care Parkinson’s Care Services
Sharp Home Care Parkinson’s Care ServicesSharp Home Care Parkinson’s Care Services
Sharp Home Care Parkinson’s Care Services
Mike Bike
 

Similar to parkinsons disease.pptx (20)

Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
 
Parkinson’s disease and exercise
Parkinson’s disease and exerciseParkinson’s disease and exercise
Parkinson’s disease and exercise
 
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
 
Cerebral palsy ppt
Cerebral palsy pptCerebral palsy ppt
Cerebral palsy ppt
 
Parkinson handbook
Parkinson handbookParkinson handbook
Parkinson handbook
 
Parkinson disease pd
Parkinson disease pdParkinson disease pd
Parkinson disease pd
 
Dr Jim George - Parkinson's Disease Service in Cumbria
Dr Jim George - Parkinson's Disease Service in CumbriaDr Jim George - Parkinson's Disease Service in Cumbria
Dr Jim George - Parkinson's Disease Service in Cumbria
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
Degenerativers
DegenerativersDegenerativers
Degenerativers
 
Parkinson’s disease and exercise
Parkinson’s disease and exerciseParkinson’s disease and exercise
Parkinson’s disease and exercise
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
Cerebral Palsy
Cerebral PalsyCerebral Palsy
Cerebral Palsy
 
my seminar p.p
my seminar p.pmy seminar p.p
my seminar p.p
 
Parkinson study case
Parkinson study caseParkinson study case
Parkinson study case
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
2009 Summer Newsltr Parkinson Ali
2009  Summer Newsltr Parkinson Ali2009  Summer Newsltr Parkinson Ali
2009 Summer Newsltr Parkinson Ali
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 
Sharp Home Care Parkinson’s Care Services
Sharp Home Care Parkinson’s Care ServicesSharp Home Care Parkinson’s Care Services
Sharp Home Care Parkinson’s Care Services
 

Recently uploaded

Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 

Recently uploaded (20)

Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 

parkinsons disease.pptx

  • 1. Presented By: Maria Kousar (Trainee Teacher) Senior Electives (Clinical Education) POST RN BSN session 2021 - 2022 2nd year Semester IV Parkinson’s disease (PD) 0
  • 2. By the end of this presentation learners will be able:  To Define Parkinson’s disease  To develop knowledge about stages of Parkinson's disease  To explain causes and clinical manifestation of Parkinson's disease  To enlist risk factors and etiology of Parkinson's disease  To describe diagnostic evaluation of Parkinson's disease  To elaborate Medical management of PD  To explain nursing management of PD Parkinson’s disease (PD) 1
  • 3. Parkinson's disease is a degenerative and slowly progressive disease that affects the nervous system and the parts of the body which controlled by nerves. Parkinson's disease is caused by a loss of nerve cells in the part of the brain called the substantia nigra. Nerve cells in this part of the brain are responsible for producing a chemical called dopamine Parkinson’s disease (PD) 2
  • 4.  Genetics  Environmental factors  Drug induced (anti psychotic drugs)  Cerebrovascular disease (Its attack damage the brain cells)  The presence of Lewy bodies (Clumps of specific substances within brain cells)  Head trauma  Advancing of age  Gender Parkinson’s disease (PD) 3
  • 5. Destruction of dopmenergic neuronal cells in the substantia nigra in the basal ganglia Neuronal cells loss and depigmentation Degeneration of dopmenergic activity Depletion of dopamine store Imbalance between acetylcholine and dopamine neurotransmitter Etiological Factors Environmental factors Genetics Brain Trauma Sign and symptoms Tremors Rigidity Akinesia Postural instability Impairment of extrapyramidal tract controlling body movements Parkinson’s disease (PD) 4
  • 7. Tremors (pill rolling usually during rest) Rigidity (stiffness of muscles) Bradykinesia (slow and small movements) Postural changes (imbalance, falls) Parkinson’s disease (PD) 6
  • 8.  Resting tremor  Mask like facial expressions  Stiff or achy limbs  Rigidity  Stooped posture (shuffle walk)  Impaired posture and balance  Loss of automatic movements  Speech changes (low or soft voice)  Trouble getting out from chair Parkinson’s disease (PD) 7
  • 9.  Patient history  Detailed physical examination  Complete neurological examination  PET scan (positron emission topography)  MRI (Magnetic resonance imaging) Parkinson’s disease (PD) 8
  • 10.  Dopamine agonists  MAO B inhibitors  Antiparkinson: drugs such as Levodopa (L-dopa); carbidopa-levodopa (Sinemet) is used to control tremors and rigidity; converted to dopamine in the basal ganglia.  Antiviral drugs: such as Amantadine hydrochloride (Symmetrel) is used to control tremor and rigidity by increasing the release of dopamine to the basal ganglia.  Anticholinergics: such as Trihexyphenidyl (Artane); benztropine mesylate (Cogentin) is used to block acetylcholine stimulated nerves that lead to tremors.  Other Drugs: Antihistamines are sometimes prescribed with the anticholinergics to inhibit dopamine uptake; bromocriptine mesylate, a dopamine antagonist, is ordered to stimulate dopaminergic receptors. Parkinson’s disease (PD) 9
  • 11.  Deep Brain Stimulation: In deep brain stimulation (DBS), surgeons implant electrodes into a specific part of the brain. The electrodes are connected to a generator implanted in your chest near your collarbone that sends electrical pulses to your brain and may reduce your Parkinson's disease symptoms. Parkinson’s disease (PD) 10
  • 12.  Assess neurological status.  Assess ability to swallow and chew.  Provide high-calorie, high-protien, high-fiber soft diet with small, frequent feedings.  Increase fluid intake to 2000 ml/day.  Monitor for constipation.  Promote independence along with safety measures.  Avoid rushing the client with activities.  Assist with ambulation and provide assistive devices. Parkinson’s disease (PD) 11
  • 13.  Instruct the client to wear low-heeled shoes.  Encourage the client to lift feet when walking and avoid prolonged sitting.  Provide a firm mattress, and position the client prone, without a pillow, to facilitate proper posture.  Instruct in proper posture by teaching the client to hold the hands behind the back to keep the spine and neck erect.  Promote physical therapy and rehabilitation.  Administer anticholinergic medications as prescribed to treat tremors and rigidity and to inhibit the action of acetylcholine. Parkinson’s disease (PD) 12
  • 14.  Imbalanced nutrition less than body requirements related to parkinsonism changes in musculature and facial rigidity as evidenced by weight lose.  Impaired Physical Mobility related to Parkinson’s disease as evidenced by immobility and weakness.  Impaired Verbal Communication related to rigidity of facial muscles evidenced by inability to speak  Constipation related to diminished motor function and inactivity. Parkinson’s disease (PD) 13
  • 15.  Assess patient’s ability to eat to provide information regarding factors associated with reduced intake of nutrients.  Weight patient daily, on the same scale and same time if possible Provides information about weight loss or gain.  Instruct patient with techniques that initiate movement change from side to side helps to start the leg movement.  Provide warm baths and massages helps relax muscles and relieve painful muscle spasms that accompany rigidity.  Assess the patient’s ability to speak, language deficit, cognitive or sensory impairment his helps identify problem areas and speech patterns to help establish a plan of care. Parkinson’s disease (PD) 14
  • 16.  Use simple, direct questions requiring one-word answers promotes self- confidence of the patient who is able to achieve some degree of speech or communication.  Instruct patient to perform daily exercise that will increase muscle strength and exercise prevent contractures.  Refer patient to a physical therapist to be helpful in developing an individualized exercise program and can provide instruction to the patient and caregiver on exercising safely.  When communicating with patient, face patient and maintain eye contact Clarity, brevity, and time provided for responses promotes the opportunity for successful speech Parkinson’s disease (PD) 15
  • 17.  To assist in maintaining balance, concentrate on taking larger steps with feet apart, keeping back straight and swinging the arms.  To overcome Akinesia, tape the “frozen” leg to initiate movement.  To reduce tremors, hold objects (coins, keys, or purse) in the hand.  To obtain partial control of tremors when seated, grasp chair arms.  To reduce rigidity before exercise, take a warm bath.  Teach the patient to eliminate loose carpeting, install grab bars, and elevate the toilet seat. Parkinson’s disease (PD) 16
  • 18.  Assist with ambulation and provide assistive devices.  Assist during meals  Maintain fluid balance  Emotional support  Provide physiotherapy services to the patient . Encephalitis In olders above 60y of age  Tremors  Rigidity  Bradykinesia  Postural changes  MAO B  Dopamine Agonist  Antiparkinson’s  Anticholinergics  I/v fluid therapy Definition Pharmacological Treatment 4 cardinal S & S Diagnostic criteria N-Management PD is a slowly progressive and degenerative disease of the brain  Health history  Complete physical examination  Complete neurological examination  CT- scan  MRI Most commonly in males Parkinson’s disease (PD) 17
  • 20. 1)The slowly progressive and degenerative disease of the brain is called.. a) Meningitis b) Encephalitis c) Parkinson's disease d) Brain abscess 2) There are how many cardinal symptoms .. a) 3 b) 4 c) 6 d) 5 Parkinson’s disease (PD) 19
  • 21. 3) Parkinson's is disease most common in.. a) Males b) Females c) Both d) None of above 4) Which of the following is recognized as an initial cardinal sign present early in Parkinson disease? a) Bradykinesia b) Balance impairment c) Hyperkinesia d) Dysarthriass Parkinson’s disease (PD) 20
  • 22. • Jankovic, J. (2008). Parkinson’s disease: clinical features and diagnosis. Journal of neurology, neurosurgery & psychiatry, 79(4), 368-376. • Dauer, W., & Przedborski, S. (2003). Parkinson's disease: mechanisms and models. Neuron, 39(6), 889-909. • Lotharius, J., & Brundin, P. (2002). Pathogenesis of Parkinson's disease: dopamine, vesicles and α- synuclein. Nature Reviews Neuroscience, 3(12), 932-942. • https://youtu.be/AZRq15AD4yA Parkinson’s disease (PD) 21